Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaku

Showing results (181-190 of 4,031) with videos related to

Pageof 404
Sort By:
Plos Pathogens|February 11, 2026
Interferon-β induction heterogeneity during KSHV infection is correlated to levels and activation of the transcription factors ATF2 and RelA, and not IRF3Machika Kaku, Marta Maria Gaglia
Environmental Science and Pollution Research International|September 2, 2020
Testing for the existence of the Environmental Kuznets Curve (EKC) for CO<sub>2</sub> emissions in Ghana: evidence from the bootstrap rolling window Granger causality testMichael Kaku Minlah, Xibao Zhang
Neural Regeneration Research|July 14, 2023
Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer's diseaseAllison R Balaj, Hiroaki Kaku
Genes and Immunity|August 28, 2009
Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoterH Kaku, T L Rothstein
Seminars in Neurology|October 23, 2019
Neuropathy Associated with Systemic AmyloidosisMichelle Kaku, John L Berk
Neural Regeneration Research|May 29, 2024
A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron deathAllison R Balaj, Hiroaki Kaku
Muscle & Nerve|October 21, 2017
HIV, antiretrovirals, and peripheral neuropathy: A moving targetMichelle Kaku, David M Simpson
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2009
Fas apoptosis inhibitory molecule expression in B cells is regulated through IRF4 in a feed-forward mechanismHiroaki Kaku, Thomas L Rothstein
Handbook of Clinical Neurology|April 2, 2018
Neuromuscular complications of HIV infectionMichelle Kaku, David M Simpson
Seminars in Neurology|October 23, 2025
Successes and Challenges in Program AdministrationVicki L Shanker, Michelle Kaku
Pageof 404

Showing results (181-190 of 4,031) with videos related to

Sort By:
Pageof 404
Plos Pathogens|February 11, 2026
Interferon-β induction heterogeneity during KSHV infection is correlated to levels and activation of the transcription factors ATF2 and RelA, and not IRF3Machika Kaku, Marta Maria Gaglia
Environmental Science and Pollution Research International|September 2, 2020
Testing for the existence of the Environmental Kuznets Curve (EKC) for CO<sub>2</sub> emissions in Ghana: evidence from the bootstrap rolling window Granger causality testMichael Kaku Minlah, Xibao Zhang
Neural Regeneration Research|July 14, 2023
Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer's diseaseAllison R Balaj, Hiroaki Kaku
Genes and Immunity|August 28, 2009
Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoterH Kaku, T L Rothstein
Seminars in Neurology|October 23, 2019
Neuropathy Associated with Systemic AmyloidosisMichelle Kaku, John L Berk
Neural Regeneration Research|May 29, 2024
A novel approach to Parkinson's disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron deathAllison R Balaj, Hiroaki Kaku
Muscle & Nerve|October 21, 2017
HIV, antiretrovirals, and peripheral neuropathy: A moving targetMichelle Kaku, David M Simpson
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2009
Fas apoptosis inhibitory molecule expression in B cells is regulated through IRF4 in a feed-forward mechanismHiroaki Kaku, Thomas L Rothstein
Handbook of Clinical Neurology|April 2, 2018
Neuromuscular complications of HIV infectionMichelle Kaku, David M Simpson
Seminars in Neurology|October 23, 2025
Successes and Challenges in Program AdministrationVicki L Shanker, Michelle Kaku
Pageof 404